Rhabdomyosarcoma (RMS) is a common cancer found in children and young adults. This cancer shares many characteristics with muscle, and the most common type is called fusion-negative RMS (FN-RMS), which is the subject of my work. While patients with RMS often have good outcomes, those whose cancer has spread (metastasized) face a very poor prognosis, with less than 20% surviving. This highlights the urgent need to understand how RMS spreads and eventually kills patients.


